Skip to main content

Table 2 Serum pro-inflammatory cytokine Levels amongst HIV infected subjects before commencement of HAART, 6 months into HAART and 1 year into HAART (±SD)

From: The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects

Group IL-6 (Pg/ml) INF-γ (Pg/ml) TNF-α (Pg/ml)
Before commencement of HAART {a} (n = 50) 18.34 ± 5.83 0.78 ± 0.06 41.32 ± 12.99
6 Months into HAART{b} (n = 50) 10.43 ± 4.98 2.25 ± 0.91 29.32 ± 10.51
1 Year into HAART{c} (n = 50) 7.05 ± 3.43 2.64 ± 0.96 15.98 ± 4.81
Control {d} (n = 50) 4.62 ± 1.04 4.89 ± 0.23 9.40 ± 3.52
F Value 60.90 11.37 75.62
P Value 0.00 0.02 0.00
{a} Vs {b} P < 0.05 P < 0.05 P < 0.05
{a} Vs {c} P < 0.05 P < 0.05 P < 0.05
{a} Vs {d} P < 0.05 P < 0.05 P < 0.05
{b} Vs {c} P < 0.05 P < 0.05 P < 0.05
{b} Vs {d} P > 0.05 P < 0.05 P < 0.05
{c} Vs {d} P > 0.05 P < 0.05 P < 0.05
  1. IL-6 Interleukin 6, INF-γ Interferon Gamma, TNF-α Tumour Necrosis Factor alpha, Vs Versus, HAART Highly Active Antiretroviral Therapy, n number of participants